PRIMARY EFFUSION LYMPHOMA
Clinical trials for PRIMARY EFFUSION LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY EFFUSION LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY EFFUSION LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug SGR-1505 enters human testing for blood cancers
Disease control Recruiting nowThis early-phase trial tests a new drug, SGR-1505, in about 98 adults with various B-cell blood cancers (like lymphoma or leukemia). The main goals are to check safety, find the best dose, and see how the body handles the drug. Participants must have a confirmed diagnosis and be …
Matched conditions: PRIMARY EFFUSION LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
Scientists seek tissue samples to unlock Virus-Cancer secrets
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, tumor, and other tissue samples from adults with HIV, KSHV, or certain cancers. The goal is to gather samples for research, not to provide treatment. Up to 999 participants will donate samples over time to help scientists learn more about t…
Matched conditions: PRIMARY EFFUSION LYMPHOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC